Advertisement
New Zealand markets closed
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NZD/USD

    0.5885
    -0.0020 (-0.34%)
     
  • NZD/EUR

    0.5525
    -0.0019 (-0.35%)
     
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • OIL

    82.29
    -0.44 (-0.53%)
     
  • GOLD

    2,395.90
    -2.10 (-0.09%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,828.93
    -48.12 (-0.61%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,705.04
    -132.36 (-0.74%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • NZD/JPY

    90.9450
    -0.3090 (-0.34%)
     

Eli Lilly's COVID-19 Treatment Candidate Will Be the First Tested in NIH's Phase 3 Study

Eli Lilly's COVID-19 Treatment Candidate Will Be the First Tested in NIH's Phase 3 Study

The National Institutes of Health is starting a head-to-head trial of several antibody treatment candidates.